Germany· DE-A57-719caea10e91a7c6
Myocholine
A bethanechol product containing bethanechol chloride, registered in Germany by Pädia Gmbh, De, Heppenheim. The same ATC class is registered in 9 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Bethanechol is registered in 9 of 19 countries.
Countries holding a registration under ATC N07AB02 (bethanechol), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 5 of them publish a price we can compare per daily dose
Bethanechol · ATC N07AB02
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Germany
- Japan
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Bethanechol Chloride
- Manufacturer
- Pädia Gmbh, De, Heppenheim
- Country
- Germany (DE)
- ATC code
- N07AB02
- ATC class
- Bethanechol
- Defined daily dose
- 45 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
38 interactions on record for bethanechol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bethanechol · interactions on record
38 records
- 4 severe
- 31 moderate
- 3 info
Most severe, free to view
- BupropionN06AX12severe
- BupropionN07BA02severe
- IohexolV08AB02severe
- IopamidolV08AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bethanechol in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBethanechol ChlorideAmneal Pharmaceuticals of New York LLC
- United KingdomBethanechol chloride 1.8mg/5ml oral solutionSpecial Order
- CanadaDUVOIDENDO OPERATIONS LTD.
- FinlandMyocholine-Glenwood
- SwitzerlandMyocholine-Glenwood 10 mg, TablettenCPS Cito Pharma Services GmbH
- BelgiumMyocholine Glenwood 10 mgGlenwood
- Japanベタネコール塩化物アルフレッサファーマ
- NorwayMyocholineGlenwood
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Austria · Myocholine
- Belgium · Myocholine
- Cyprus · Myocholine
- United Kingdom (Northern Ireland) · Bethanechol Chloride Infectopharm Arzneimittel Und Consilium Gmbh
- Luxembourg · Myocholine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cad8fd7e-4d3b-4e75-a8ed-fe05ff07ce34 GET /v1/drugs/cad8fd7e-4d3b-4e75-a8ed-fe05ff07ce34?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Bethanechol Chloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about bethanechol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.